Stage III melanoma (after surgery)

What changed: Stage III melanoma (after surgery)

Cancer page →

Every dated change on the records linked to Stage III melanoma (after surgery), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Regulatory1Trial result7Milestone8This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordStage III melanoma (after surgery)
Facts on this page last checked
When this page itself was last checked or edited.

2026 · 2

2025 · 1

2025Trial resultRELATIVITY-098
RELATIVITY-098 reported
RFS not improved.

2024 · 2

2023 · 1

2023MilestoneIntismeran autogene
KEYNOTE-942: intismeran autogene plus pembrolizumab lowers relapse in phase 2b
A milestone in how this cancer is treated.

2022 · 2

2018 · 1

2018MilestoneStudy of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)
KEYNOTE-054: adjuvant pembrolizumab beats placebo
A milestone in how this cancer is treated.

2017 · 4

October 2015 · 1

2015-10-28RegulatoryIpilimumab
Ipilimumab: approval (US)
Adjuvant stage III melanoma (10 mg/kg; later superseded)

2015 · 1

2015MilestoneIpilimumab
EORTC 18071: adjuvant ipilimumab improves relapse-free and overall survival at high toxicity
A milestone in how this cancer is treated.

1996 · 1

1996MilestoneInterferon alfa-2a/2b
ECOG 1684: high-dose interferon alfa becomes the first adjuvant therapy
A milestone in how this cancer is treated.